Company intelligence / Profile preview
Wockhardt
Mumbai, Maharashtra, Indiawockhardt.com ↗
- Ownership
- Public · WOCKPHARMA
- Employees
- ~3000
- Development stage
- Other
01
Overview
Wockhardt has 5 New Chemical Entities (NCEs) with QIDP status from US FDA that are in Phase II & Phase III clinical trials[6]
- Therapeutic areas
- CardiovascularRheumatologyNephrologyEndocrinologyDermatologyOtherWomen's HealthNeurology
- Modalities
- FormulationsBiopharmaceuticalsVaccinesActive Pharmaceutical Ingredients (APIs)BiosimilarsNew Chemical Entities (NCEs)
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
UK Government (for COVID-19 vaccine fill-finish)Enso HealthcareHuman Vaccine LLC (for Sputnik V and Sputnik Light vaccines)[1]
04
Financials
- Market cap
- $754.9B
- Total revenue
- $681B
Beyond the preview
Go deeper on Wockhardt.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wockhardt.